Materi MIMBAR 20 - BPK Hadi

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 20

Presented at MIMBAR TROBOS

Aug 12th ,2021


Drh. Setia Hadi
Technical Sales Manager
Phibro Animalhealth

August 12, 2021 [Presentation Title] Confidential


OVERVIEW

August 12, 2021 [Presentation Title] Confidential


OVERVIEW
Gumboro disease – important disease of chickens

IBD is a highly contagious viral disease of chickens that can lead to heavy losses due to direct
mortality, immunosuppression & secondary infections

The pathogen is a non-enveloped double stranded RNA Enterovirus

Gumboro typically effects young chickens 1-6w of age, the primary target organ is the Bursa of
Fabricius where IgM+ immature B-Lymphocytes are the target cells

IBDV is a worldwide endemic disease, appears as vvIBDV or sub-clinical (variant) and almost every
commercial chicken in the world is vaccinated against Gumboro

Phivax MB-1 Confidential


OVERVIEW
How do we protect the chickens from Gumboro?
The IBDV is infecting young birds so protection is targeted to protect the birds until 8-9 weeks of age.

Besides biosecurity, vaccination is the most important measure for IBDV control and anti-VP2
antibodies are very effective.

Maternal antibodies will protect young chicks in the first 2-3 weeks of life when their B-lymphocytes
are most vulnerable to IBDV infection.

Breeder vaccination for high levels of maternal immunity, passive immunity, followed by active
immunization of the progeny is an effective mode of protection.

Phivax MB-1 Confidential


IBD VACCINE

August 12, 2021 [Presentation Title] Confidential


IBD VACCINE
Evaluation of the current live Gumboro vaccines solutions

VP2

Vaccine Live conventional Immune complex Vector


Main Advantage Early protection Hatchery application Hatchery application
Main Not a live Gumboro,
Application Delayed OOI
Disadvantage delayed OOI

Phivax MB-1 Confidential


*Jeurissen et al, 1998

Phivax MB-1 Confidential


Evaluation of the current live Gumboro vaccines solutions
VP2

Live
Vaccine Immune complex Vector • Hatchery
conventional
application
Main Early Hatchery Hatchery
• Individual
Advantage protection application application
vaccination
Not a live • Early
Main
Application Delayed OOI Gumboro, protection
Disadvantage
delayed OOI

Phivax MB-1 Confidential


SOLUTION

August 12, 2021 [Presentation Title] Confidential


▪ Live attenuated vaccine for Infectious Bursal Disease (IBD), containing
the MB strain
▪ In-ovo or subcutaneous injection in the hatchery
▪ Adjusts to IBD maternally derived antibodies of the individual chick

▪ Single dose protects for the lifetime of the bird


▪ Earlier onset of immunity compared to immune-complex and IBD recombinant
vaccines -4 days in average
▪ Proven safety and highly effective
SOLUTION ▪ Protects against all forms of the IBD virus: Classic, Very Virulent & Variant

▪ Safe for broiler, layer, and breeder

Phivax MB-1 Confidential


2019 Deventer Lab trial
Trial by J.J. de Wit, Deventer, Holland

Objective: Determination of the protection conferred by MB-1 IBD vaccine administered to


commercial broilers (Ross 308 with MDA) by the in ovo application against vvIBDV challenge
at 22 and 36 days of age and compare it to that of ICX vaccine by Serology, B2BWR, BLS,
PCR and Challenge.

Group Vaccine Challenge age(d)

TG01 MB-1 22
Post hatch, the birds were TG02 MB-1 36
placed in 6 isolators TG03 ICX 22

TG04 ICX 36

TG05 Control Not vac. 22

TG06 Control Not vac. 36

Phivax MB-1 Confidential


RESULT
VACCINATION GUMBORO ANTIBODIES NO. % MEAN MEAN MEAN
GROUP NUMBER
CHALLENGE
OF BIRDS in ovo ELISA (GMT) HOMOLOGY GENOTYPE BBWR BLS
Ct-
POS
VALUE * **
0 D22 D36 D0 D7 D14 D22 D28 D36 10 d.p.c.
DOC 18 - - - - - - -

TG01 30 MB-1 vvIBD - 174 133 - 10 100% MB-1 vaccine 23.2 0.66 3.20

8 100% MB-1 vaccine

TG02 30 MB-1 - vvIBD 213 270 1402 2884


Could not be
29.5 0.71 2.50
2 n.a.
assessed

9 100% W2512

TG03 20 ICX vvIBD - 3741 1113 123 99 - - Mixture of 24.1 0.66 2.80
1 n.a. W2512 and
vvIBDV

vvIBDV
TG04 20 ICX - vvIBD 230 51 101 38 10 100%
DV86
22.3 0.69 4.80

vvIBDV
TG05 20 Not Vac. vvIBD - 277 15 - - 10 100%
DV86
19.2 0.74 4.60

vvIBDV
TG06 20 Not Vac. - vvIBD 315 14 5 13 10 100%
DV86
21.1 0.69 4.50

Phivax MB-1 Confidential


CONCLUSION
The in ovo vaccination with MB-1 of the commercial broilers was able to induce full protection
against a challenge with vvIBDV at 22 days and 36 days of age.

The results of the challenge of the ICX vaccinated broilers of TG04 (challenged at D36) showed
that the vaccination had not induced any level of protection. At 22D challenge it is estimated that
the challenge was at the same time of 2512 replication

Phivax MB-1 Confidential


Phivax MB-1 Confidential
Phivax MB-1 Confidential
The IBDV ELISA titers, BBWR, BF lesion score, and IBDV
molecular detection data indicated an earlier viral replication in
the MB-1 groups vs. the two Icx vaccines groups in trials 1 and 3
and a similar timing of replication in the MB-1 groups vs. the
TAbic M.B. groups in trials 2 and 4. It appeared that in the
presence of adequate levels of maternal antibodies, the MB-1
replication initiated between 21 and 28 DOA, and not prior to 21
DOA, while the Icx vaccines replication initiated between 24 and
32 DOA.

Phivax MB-1 Confidential


List of field comparison studies (2017 - 2019)
Finished
Country Year/ No of trials Birds Birds
trials
Trials took place in different Israel 2016/ 1 12,000 1 12,000
countries, seasons and
management conditions from RSA 2016-2018 / 8 2,714,000 8 2,714,000
deep-litter to fully controlled
houses
Argentina 2017-2019 / 17 12,279,000 12 5,379,000
MB-1 was injected In-OVO or
SC
Brazil 2017-2018 / 5 1,667,491 5 1,667,491
All trials included monitoring
of immune parameters, PCR Russia 2019 / 2 514,560 2 514,560
and performance
All results are statistically Indonesia 2019 / 1 38,000 1 38,000
analyzed
Not even a single failure to India 2019 / 2 16,150 2 9,650
provide protection
TOT 2016-2019 / 36 17,229,201 31 10,452,191

Phivax MB-1 Confidential


INDONESIA MILESTONE
• MB-1 launched on March 2021.

• More than 100 M doses MB-1 commercially used ever since to layer and
broiler farms.

• Some hatchery already apply MB-1 on their operation.

• At least 8 broiler farm (>500.000 birds) and 10 layer farm (>250.000 birds)
have been observed.

Phivax MB-1 Confidential


VIDEO
August 12, 2021 [Presentation Title] Confidential
Phivax MB-1 Confidential

You might also like